Dr. Adibi's research consists of biomedical studies including devices to solve diagnostic challenges and treatment options for Temporomandibular Disorders (TMD) and Nocturnal Bruxism (night time grinding of teeth). TMD consists of a number of clinical conditions that involve the TMJ, the muscles of mastication...
Dr. Fakhouri’s laboratory research investigates genetic and epigenetic factors that are essential for early craniofacial development; and disruptions in these factors that cause and contribute to congenital craniofacial defects, including cleft lip and palate, craniosynostosis and micrognathia.
Membrane trafficking is crucial for the formation and maintenance of cellular structures. Recent studies indicate that membrane trafficking is disrupted in a variety of human diseases; however, the regulatory mechanism of membrane trafficking remains largely unknown. The aim of my laboratory is to understand...
The Kasper Laboratory applies fundamentals of engineering, materials science, and the biosciences toward the development and evaluation of biomaterial-based technologies to meet clinical needs, with a particular focus on 3D printing and tissue regeneration.
Understanding resolution of inflammation in periodontal diseases. Investigating novel approaches to diagnose and treat periodontal diseases.
My research laboratory tackles challenging pharmacological conundrums, such as the adverse health consequences of toxicokinetic drug interactions with drugs, medicinal therapies, and drugs of abuse (areca nut). Additionally, we aim to better characterize the public health ramifications of areca (betel)...
Bones & Teeth Lab at the UTHealth Houston School of Dentistry led by Drs. Wanida and Noriaki Ono, orthodontist-scientist investigators: Leveraging advanced mouse genetic approaches to address fundamental questions on growth and development, health and diseases of bones and teeth.
The focus of our current research is to develop novel material-based immunotherapies for the treatment of head and neck cancer and explore mechanisms of how this approach may synergize with other modalities of treatment such as chemo/radiation therapy. The paradigm of in situ cell programming using biomaterials...